COVID-19 Impact on Newly Diagnosed Breast Cancers at Regional Cancer Centre, Thiruvananthapuram—An Audit

Abstract

Geethu Babu

The coronavirus pandemic has created havoc in every aspect of life including cancer care and was declared a pandemic. This audit was conducted to study the impact of the pandemic on diagnosis and treatment of newly diagnosed breast cancer patients at a tertiary cancer center in South India. A total of 1,647 patients who registered at Regional Cancer Centre (RCC), Thiruvananthapuram, Kerala, India for breast cancer during the period April 1, 2020, to September 30, 2020 (COVID-19 period) as well as April 1, 2019, to September 30, 2019 (pre-COVID-19 period) were included in the study. Data regarding the geographic distribution, stage at presentation, time factors for reporting for care, diagnosis, and treatment, referral for care elsewhere were collected and analyzed. The study was approved by the Institutional Review Board. Means and ranges were calculated for continuous type variables, and numbers and percentages for categorical variables. To determine whether there were significant differences between the two groups, independent t-test was used for continuous variables and chi-square test for categorical type of variables. A notable reduction (36%) in newly diagnosed breast cancer patients was seen in 2020 when compared with 2019. There was a significant difference in the geographic distribution of patients in both cohorts (p = 0.001) and a notable reduction in the number of patients reporting to RCC for treatment from the northern districts of Kerala (81%) and outside Kerala (89.5%). There was no significant difference in the time (in weeks) since symptom onset and reporting to hospital or the clinical stage at diagnosis between the groups. Also, coronavirus disease 2019 (COVID-19) did not seem to negatively impact time intervals between date of registration and pathological diagnosis or start of primary treatment. More patients received neoadjuvant systemic therapy during 2020 compared with 2019, and this difference was statistically significant (p = 0.004). There was no difference in the type of surgery (breast-conserving surgery vs. modified radical mastectomy). The results demonstrate that COVID-19 did not appear to negatively impact the diagnosis and treatment of newly diagnosed breast cancer patients. However, this is largely attributable to the significantly less number of patients who registered, for whom the departments were able to maintain timely cancer care despite the difficult pandemic times. Significantly more patients received neoadjuvant systemic therapy in 2020.

Keywords

COVID-19 - breast cancer - newly diagnosed - impact - audit

Authors' Contribution

G.B. performed the literature search, collected the data, and prepared the manuscript. K.K.R was involved in the design of the study and preparation of the manuscript. A.M. was involved in the statistical analysis and preparation of manuscript. B.P., A.A., P.A., K.C., R.J., and N.R. were involved in the design of the study. R.B. was involved in the design of the study and preparation of manuscript. B.S.M. designed the study, supervised the conduct of the study, interpreted results, and edited the manuscript.

Publication History

Article published online:
12 February 2024

• References

• 1 Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
• 2 356-india-fact-sheets.pdf Accessed December 03, 2022 at: https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf
• 3 Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91 (01) 157-160
• 4 London JW, Fazio-Eynullayeva E, Palchuk MB, Sankey P, McNair C. Effects of the COVID-19 pandemic on cancer-related patient encounters. JCO Clin Cancer Inform 2020; 4: 657-665
• 5 Ferrara G, De Vincentiis L, Ambrosini-Spaltro A. et al. Cancer diagnostic delay in Northern and Central Italy during the 2020 lockdown due to the coronavirus disease 2019 pandemic. Am J Clin Pathol 2020; •••: aqaa177
• 6 Li J, Wang H, Geng C. et al. Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: a national survey of 8397 patients in the first quarter of 2020. EClinicalMedicine 2020; 26: 100503
• 7 Ranganathan P, Sengar M, Chinnaswamy G. et al; National Cancer Grid of India. Impact of COVID-19 on cancer care in India: a cohort study. Lancet Oncol 2021; 22 (07) 970-976
• 8 Nnaji CA, Moodley J. Impact of the COVID-19 pandemic on cancer diagnosis, treatment and research in African health systems: a review of current evidence and contextual perspectives. Ecancermedicalscience 2021 Jan 14 15: 1170
• 9 Dinmohamed AG, Visser O, Verhoeven RHA. et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol 2020; 21 (06) 750-751
• 10 Mentrasti G, Cantini L, Vici P. et al. Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study. Breast 2022; 65: 164-171
• 11 Koca B, Yildirim M. Delay in breast cancer diagnosis and its clinical consequences during the coronavirus disease pandemic. J Surg Oncol 2021; 124 (03) 261-267
• 12 Tang A, Neeman E, Vuong B. et al; Permanente Medical Group Breast Research Collaborative. Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system. Breast Cancer Res Treat 2022; 191 (03) 665-675
• 13 Pulla P. COVID-19: India imposes lockdown for 21 days and cases rise. BMJ 2020; 368: m1251
• 14 Losurdo A, Lisa AVE, Tomatis M. et al; Senonetwork Working Group. Highly specialized breast centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience. Breast Cancer Res Treat 2022; 196 (01) 87-95
• 15 Gupta A, Yadav BS, Gade VKV, Rana D, Bharti D, Dahiya D. Delays and disruptions in breast cancer care due to coronavirus disease-2019 pandemic: real-world data from India. Ann Oncol Res Ther 2022; 2: 23-28
• 16 Samson K. COVID-19 severely delayed breast cancer care at urban hospital. Oncology Times 2022; 44 (09) 21
• 17 Sharpless NE. COVID-19 and cancer. Science 2020; 368 (6497): 1290
• 18 Romics L, Doughty J, Stallard S. et al. A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland. Breast 2021; 55: 1-6
• 19 Tonneson JE, Hoskin TL, Day CN, Durgan DM, Dilaveri CA, Boughey JC. Impact of the COVID-19 pandemic on breast cancer stage at diagnosis, presentation, and patient management. Ann Surg Oncol 2022; 29 (04) 2231-2239
• 20 Kara H, Arikan AE, Dulgeroglu O, Tutar B, Tokat F, Uras C. Has the COVID-19 pandemic affected breast cancer stage and surgical volume?. Front Surg 2022; 9: 811108